Montvale Technologies Inc
OTC:IVVI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Montvale Technologies Inc
OTC:IVVI
|
US |
|
K
|
KSE Ltd
BSE:519421
|
IN |
|
M
|
MITCON Consultancy & Engineering Services Ltd
NSE:MITCON
|
IN |
|
Sunshine Biopharma Inc
NASDAQ:SBFM
|
CA |
|
En+ Group MKPAO
MOEX:ENPG
|
RU |
|
Enzon Pharmaceuticals Inc
OTC:ENZN
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IVVI's stock price target?
Not Available
IVVI doesn't have any price targets made by Wall Street professionals.
What is Montvale Technologies Inc's Revenue forecast?
Projected CAGR
10%
For the last 3 years the compound annual growth rate for Montvale Technologies Inc's revenue is 23%. The projected CAGR for the next 1 year is 10%.